Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m)
Front Psychiatry. 2023 Jan 19:13:1079006.
doi: 10.3389/fpsyt.2022.1079006.
eCollection 2022.
1 Departments of Radiology, Neurology, and Psychological Sciences, William and Nancy Thompson Endowed Chair in Radiology, University of Missouri, Columbia, MO, United States.
2 Holland Bloorview Kids Rehabilitation Hospital, University of Toronto, Toronto, ON, Canada.
3 Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.
4 Clinical Research Associates LLC, Simons Foundation, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, United States.
5 Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
6 Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
7 Department of Psychology, John Carroll University, University Heights, OH, United States.
8 Department of Pediatrics, State University of New York Upstate Medical University, Syracuse, NY, United States.
9 Departments of Psychiatry and Pediatrics, New York State Psychiatric Institute, Columbia University, New York, NY, United States.
10 NewYork-Presbyterian Center for Autism and the Developing Brain, New York, NY, United States.